Marker Therapeutics stockholders elect directors, approve say-on-pay, ratify auditor at 2025 annual meeting

Marker Therapeutics, Inc.

Four director nominees elected: Eansor (4.1M for), Elms (4.1M), Knobil (4.1M), Vera (4.1M); broker non-votes 2.8M.
Advisory vote on named executive officer compensation passed: 4.45M for, 343K against, 13.9K abstain.
Ratification of Marcum LLP as independent auditor for FY2025: 7.49M for, 80.8K against, 53.9K abstain.
Total shares outstanding 11.3M; 67.43% quorum (7.63M shares present or proxy).

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.